SCREENING FOR ACTIVE TUBERCULOSIS IN HIV TESTING CENTER

被引:23
作者
ESPINAL, MA
REINGOLD, AL
KOENIG, E
LAVANDERA, M
SANCHEZ, S
机构
[1] UNIV CALIF BERKELEY,SCH PUBL HLTH,DIV PUBL HLTH BIOL & EPIDEMIOL,BERKELEY,CA 94720
[2] NATL LAB PUBL HLTH,SANTO DOMINGO,DOMINICAN REP
[3] MINIST HLTH,NATL TB CONTROL PROGRAM,SANTO DOMINGO,DOMINICAN REP
来源
LANCET | 1995年 / 345卷 / 8954期
关键词
D O I
10.1016/S0140-6736(95)90010-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In industrialised nations HIV-seropositive individuals can be offered shin testing for tuberculosis (TB) and isoniazid prophylaxis, but this approach is neither practicable nor affordable in most developing countries. in Santo Domingo, Dominican Republic, we offered skin testing and a brief clinical examination for active TB to people requesting HIV testing at one centre. 200 newly detected HIV-positive individuals and 200 age and sex-matched HIV-negative ones were compared. 39 (9.7%) of the 400 individuals seeking HIV testing had active TB; 29 were HIV positive and 10 were HIV negative (adjusted odds ratio 3.3, 95% CI 1.3-8.7; p=0.01). In multivariate analysis, the strongest independent predictors of active TB were 10 mm or more of induration on skin testing, a history of chronic cough, lymphadenopathy, and HIV infection. Of the patients diagnosed with TB, 85% had one or more symptoms readily ascertainable in a brief screening questionnaire. Screening for TB at HIV-testing sites could be an effective approach to early detection of active TB among not just HIV-positive but also HIV-negative people. integrating screening for TB into HIV testing schemes could help to reduce the spread of TB and allow patients with TB to be diagnosed and treated earlier.
引用
收藏
页码:890 / 893
页数:4
相关论文
共 19 条
[1]  
De Cock, Soro, Malick, Lucas, Tuberculosis and HIV-infection in sub-Saharan Africa, JAMA, 268, pp. 1581-1587, (1992)
[2]  
Narain, Raviglione, Kochi, HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention, Tuber Lung Dis, 73, pp. 311-321, (1992)
[3]  
Harries, Tuberculosis and human immunodeficiency virus infection in developing countires, Lancet, 335, pp. 390-393, (1990)
[4]  
Sutherland, Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli, Adv Tuber Res, 19, pp. 1-63, (1976)
[5]  
Selwyn, Hartel, Lewis, Et al., A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection, N Engl J Med, 320, pp. 545-550, (1989)
[6]  
Snider, Raviglione, Kochi, Global burden of tuberculosis, Tuberculosis: pathogenesis, protection, and control, (1994)
[7]  
Centers for Disease Control, Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET), MMWR, 38, pp. 236-238, (1989)
[8]  
Tuberculosis preventive therapy in HIV-infected individuals a joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO), Tuber Lung Dis, 75, pp. 96-98, (1994)
[9]  
Garcia, Strains of Mycobacterium tuberculosis resistant to therapy, Neumos, 7, pp. 9-10, (1992)
[10]  
Garcia, Granados, Mycobacteria in the laboratory, Neumos, 8, pp. 169-170, (1993)